Skip to main content
Skip to main content
CHFLF logo

China Feihe Limited (CHFLF)

$0.35 +$0.00 (+0.00%) |CouncilBUY · 55 · B
Bottom line: BUY — our Council read (55/100) and AI Score (52/100) broadly agree. Strongest single signal: Ray Dalio bullish.
MCap: $3.08B| P/E Ratio: 12.7| Vol: 4.0K| 52-wk range: $0.40 – $0.71
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

China Feihe Limited (CHFLF) trades at $0.35 with AI Score 52/100 (Grade B). China Feihe Limited is an investment holding company primarily focused on producing and selling infant milk formula in Mainland China and the United States. Market cap: $3.08B, Sector: Consumer defensive.

Price live · AI analysis from Jun 14, 2026
China Feihe Limited is an investment holding company primarily focused on producing and selling infant milk formula in Mainland China and the United States. The company also diversifies its product portfolio with raw milk, adult milk powders, liquid milk, health care products, and nutritional supplements.

Analyst Coverage for CHFLF: CHFLF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CHFLF against Consumer Defensive peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
BUY 55/100 · B

CHFLF: 3/6 perspectives are bullish. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Neutral
Izzy Englander
Neutral
Seth Klarman
Bullish
Moon AI
Bullish
Council Score · 8 perspectives · See tabs for details →

China Feihe Limited (CHFLF) Consumer Business Overview

CEOYoubin Leng
Employees9590
HeadquartersBeijing, CN
IPO Year2022

China Feihe Limited, founded in 1962, is a prominent consumer defensive company specializing in infant milk formula, adult milk powders, and nutritional supplements across Mainland China and the United States. Operating through a vast distribution network and e-commerce platforms, the company maintains a significant market presence in the packaged foods industry, supported by a 65.0% gross margin.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for CHFLF?

China Feihe Limited presents an investment profile characterized by its established market presence, diversified product portfolio, and robust distribution capabilities within the consumer defensive sector. With a market capitalization of $3.08B, the company operates with a P/E ratio of 12.7 and maintains a strong gross margin of 65.0%, indicating efficient cost management. A profit margin of 10.7% further underscores its operational profitability. Key value drivers include its extensive reach in the infant milk formula market in Mainland China and the United States, complemented by a growing presence in adult nutrition and health care products. Growth catalysts are anticipated from continued expansion in e-commerce channels, leveraging platforms like Tmall and JD.com, and further penetration into the adult nutritional supplement market, driven by demographic shifts and increasing health awareness. The company's substantial dividend yield of 7.83% also offers an attractive income component. However, potential risks include intense competition, regulatory changes in China's food safety standards, and fluctuations in raw material costs, which could impact its financial performance.

Based on FMP financials and quantitative analysis

CHFLF Key Highlights

  • Market Capitalization: $3.82 billion, reflecting a significant enterprise valuation within the packaged foods industry.
  • Gross Margin: 65.0%, indicating strong profitability from sales after accounting for the cost of goods sold, exceeding many industry benchmarks.
  • Profit Margin: 10.7%, demonstrating effective management of operating expenses and a healthy bottom line.
  • Dividend Yield: 7.83%, providing a substantial return to shareholders relative to its stock price.
  • Extensive Distribution Network: As of December 31, 2021, the company operated through approximately 2,000 offline customers with 110,000 retail points of sale, ensuring broad market access.

Who Are CHFLF's Competitors?

CHFLF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
TSUKF Toyo Suisan Kaisha, Ltd. $64.11 +0.00% $6.24B 49
GLAPY Glanbia plc $132.77 -3.79% $6.42B 48
NSLYF Nestlé (Malaysia) Berhad $23.76 +0.00% $5.57B
GPAGF Gruma, S.A.B. de C.V. $18.50 +2.21% $6.31B 66
PNGAF Pangea Wellness Inc. $0.37 +10.51% $5.54M 65
ZHYBF Zhong Yuan Bio-Technology Holdings Limited $2.02 +0.00% $35.75M 64
BOF BranchOut Food Inc. $4.58 -4.18% $70.15M 61
MEJHY Meiji Holdings Co., Ltd. $11.21 +0.00% $6.08B 52

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are CHFLF's Key Strengths?

  • Extensive distribution network with 110,000 retail points of sale as of December 31, 2021, ensuring broad market reach.
  • Diversified product portfolio beyond infant milk formula, including adult milk powders, health care products, and nutritional supplements.
  • Strong gross margin of 65.0%, indicating efficient cost management and potential pricing power.
  • Long operating history since 1962, contributing to brand recognition and consumer trust.
  • Established presence on major e-commerce platforms (Tmall, JD.com, Suning.com) and proprietary digital channels.

What Are CHFLF's Weaknesses?

  • High reliance on the Chinese market, making it susceptible to regional economic and regulatory shifts.
  • Potential for intense competition within the infant milk formula sector from both domestic and international brands.
  • Disclosure status on the OTC market is 'Unknown', potentially limiting investor access to timely and comprehensive financial information.
  • Specific brand names and their individual market positions are not detailed in the provided source data.

What Could Drive CHFLF Stock Higher?

  • Continued expansion of its e-commerce sales channels, leveraging platforms like Tmall and JD.com to reach a broader consumer base across China and enhance digital market penetration.
  • Diversification into adult milk powders and health care products, tapping into the growing market for nutritional supplements driven by an aging population and increasing health awareness.
  • Optimization and expansion of its extensive offline distribution network, which comprised 110,000 retail points of sale as of December 31, 2021, to further solidify market reach and product availability.
  • Potential introduction of new premium or specialized infant formula products to capture higher-value segments of the market and enhance brand positioning.
  • Strategic initiatives to deepen penetration or broaden product offerings within the United States market, expanding its international footprint.

What Are the Key Risks for CHFLF?

  • Intense competition within the infant milk formula market in China from both domestic and international brands, potentially impacting market share and pricing power.
  • Regulatory changes in China's food safety standards or import policies, which could necessitate costly operational adjustments or impact product availability.
  • Fluctuations in raw milk prices and other input costs, which could compress the company's gross margins and overall profitability.
  • Shifts in consumer preferences towards alternative feeding methods or different nutritional product categories, requiring agile product development.
  • Risks associated with trading on the OTC market, including lower liquidity, increased price volatility, and less stringent disclosure requirements, impacting investor confidence and trading efficiency.

What Are the Growth Opportunities for CHFLF?

  • **E-commerce Channel Expansion**: China Feihe Limited has a strong foundation in e-commerce, utilizing major platforms such as Tmall, JD.com, and Suning.com, alongside its proprietary website and WeChat application. Further strategic investment and optimization in these digital channels present a significant growth opportunity. The Chinese e-commerce market continues to expand rapidly, driven by increasing internet penetration and mobile shopping habits. By enhancing its digital marketing, logistics, and customer engagement strategies, China Feihe can capture a larger share of the online consumer base for both its infant formula and diversified nutritional products, potentially reaching new demographics and geographies within China and beyond. This expansion offers a scalable and cost-effective pathway to increase sales volume and market reach.
  • **Diversification into Adult Nutrition and Health Care**: The company's existing portfolio includes adult milk powders, liquid milk, health care products, vitamins, minerals, herbs, and other nutritional supplements. This segment represents a substantial growth opportunity, particularly given the aging population in China and a global trend towards increased health awareness and preventative wellness. By developing innovative products tailored to specific adult nutritional needs, such as bone health, digestive support, or immunity boosting, China Feihe can tap into a high-growth market. Leveraging its established brand reputation and distribution network, the company can effectively cross-sell these products to existing customers and attract new ones, thereby reducing its reliance on the infant formula market.
  • **Deepening Penetration in the United States Market**: While China Feihe Limited already sells infant milk formula products in the United States, there is potential for deeper market penetration and broader product offerings. The U.S. market for infant nutrition and health supplements is substantial and diverse, offering opportunities for specialized products or targeted marketing campaigns. Strategic partnerships, increased brand visibility, and adapting products to local consumer preferences and regulatory standards could unlock significant growth. Expanding its distribution channels within the U.S., potentially through specialized retailers or direct-to-consumer models, could allow the company to capture a larger share of this lucrative market, diversifying its revenue streams geographically.
  • **Premiumization of Infant Formula Products**: Within the highly competitive infant milk formula market, there is a growing consumer trend towards premium and specialized products, often driven by health-conscious parents seeking enhanced nutritional benefits or organic options. China Feihe can capitalize on this by investing in research and development to introduce higher-value, specialized infant formula lines. This could include formulas with unique ingredient profiles, advanced nutritional components, or those catering to specific dietary needs. A successful premiumization strategy would not only enhance brand perception and loyalty but also improve average selling prices and gross margins, contributing significantly to revenue growth in its core business segment.
  • **Supply Chain Optimization and Vertical Integration**: As a producer of milk-based products, efficient management of its supply chain, from raw milk sourcing to final product delivery, is critical. Opportunities exist for further vertical integration or optimization of its supply chain processes. This could involve investing in advanced dairy farming technologies, improving processing efficiencies, or enhancing logistics and inventory management systems. Such initiatives can lead to cost reductions, improved product quality control, and greater supply chain resilience against external shocks like raw material price volatility. Enhanced supply chain capabilities would provide a competitive advantage by ensuring consistent product availability and potentially improving overall profitability through operational efficiencies.

What Opportunities Does CHFLF Have?

  • Growth in the adult nutrition and health care product market, driven by an aging population and increasing health awareness.
  • Further penetration and expansion of e-commerce channels to capture a larger share of the online consumer base.
  • Deepening market presence and product offerings in the United States market.
  • Premiumization of existing product lines, particularly infant formula, to cater to discerning consumers and improve margins.
  • Optimization of supply chain and potential vertical integration to enhance efficiency and control costs.

What Threats Does CHFLF Face?

  • Ongoing intense competition from well-established domestic and international players in the packaged foods industry.
  • Potential for adverse regulatory changes in China's food safety standards or import policies.
  • Fluctuations in raw material costs, particularly for milk, which could impact profitability.
  • Shifts in consumer preferences towards alternative feeding methods or different nutritional product categories.
  • Risks associated with trading on the OTC market, including lower liquidity, increased price volatility, and less stringent disclosure requirements.

What Are CHFLF's Competitive Advantages?

  • **Extensive Distribution Network**: As of December 31, 2021, the company boasted 110,000 retail points of sale across 2,000 offline customers, providing unparalleled market access in China.
  • **Established Brand Presence**: Founded in 1962, China Feihe has a long operating history, fostering brand recognition and consumer trust in a sensitive product category like infant formula.
  • **Diversified Product Portfolio**: Beyond infant formula, offerings in adult milk powders, health care products, and supplements reduce reliance on a single product line and cater to broader consumer needs.
  • **Strong Gross Margin**: A 65.0% gross margin indicates efficient production, strong pricing power, or a favorable cost structure, allowing for competitive pricing or higher reinvestment.
  • **Integrated E-commerce Strategy**: Presence on major platforms like Tmall and JD.com, coupled with its own digital channels, provides a robust and modern sales infrastructure.

What Does CHFLF Do?

China Feihe Limited, established in 1962 and headquartered in Beijing, the People's Republic of China, operates as an investment holding company with a primary focus on the production and sale of infant milk formula products. Its market reach extends across Mainland China and into the United States, positioning it as a key player in the global packaged foods sector. Over its decades of operation, the company has strategically evolved its product portfolio beyond its core infant formula offerings. This diversification now includes a comprehensive range of raw milk, adult milk powders, and liquid milk products, catering to a broader demographic. Furthermore, China Feihe has ventured into health care products, soybean powder, and goat milk powder, alongside the retail of vitamins, minerals, herbs, and other nutritional supplements, demonstrating a commitment to addressing diverse consumer health and wellness needs. The company employs a robust, multi-channel distribution strategy to ensure widespread product availability. Its sales channels encompass traditional distributors, a significant network of e-commerce platforms such as Tmall, JD.com, and Suning.com, and direct-to-consumer engagement through its own website and mobile application, including WeChat. As of December 31, 2021, China Feihe Limited boasted an extensive offline distribution network, serving approximately 2,000 offline customers and reaching an impressive 110,000 retail points of sale. This integrated approach, combining a long-standing operational history with strategic product diversification and a broad distribution footprint, underpins its market position in the highly competitive consumer defensive industry.

What Products and Services Does CHFLF Offer?

  • Produces and sells infant milk formula products in Mainland China and the United States.
  • Offers a range of raw milk, adult milk powders, and liquid milk products.
  • Provides various health care products to consumers.
  • Sells specialized nutritional products including soybean powder and goat milk powder.
  • Engages in the retail of vitamins, minerals, herbs, and other nutritional supplements.
  • Distributes its products through an extensive network of offline customers and retail points of sale.
  • Utilizes major e-commerce platforms such as Tmall, JD.com, and Suning.com for online sales.
  • Operates its own website and mobile application, including WeChat, for direct consumer engagement and sales.

How Does CHFLF Make Money?

  • Manufacturing and distribution of a diversified portfolio of packaged food products, primarily milk-based formulas and nutritional supplements.
  • Multi-channel sales strategy combining traditional wholesale distribution with direct-to-consumer e-commerce platforms and proprietary digital channels.
  • Investment holding company structure, overseeing various operational segments within the consumer defensive sector.
  • Focus on both core infant nutrition and expanding into adult health and wellness categories to broaden revenue streams.

What Industry Does CHFLF Operate In?

China Feihe Limited operates within the Consumer Defensive sector, specifically in the Packaged Foods industry, a segment known for its relative stability due to consistent consumer demand for essential goods. The company's focus on infant milk formula, adult milk powders, and health care products positions it within a market driven by demographic trends, evolving dietary preferences, and increasing health consciousness. The competitive landscape is robust, featuring both domestic and international players, including peers like Toyo Suisan Kaisha, Ltd. (TSUKF), Glanbia plc (GLAPY), and Nestlé (Malaysia) Berhad (NSLYF). China Feihe's extensive distribution network and diversified product offerings allow it to maintain a significant footprint, particularly in the Chinese market, where it leverages both traditional retail and burgeoning e-commerce channels to capture market share amidst ongoing industry consolidation and innovation in nutritional products.

Who Are CHFLF's Key Customers?

  • Parents and caregivers seeking infant milk formula for their children.
  • Adult consumers purchasing milk powders, liquid milk, and other dairy products.
  • Individuals interested in health care products, vitamins, minerals, herbs, and nutritional supplements.
  • A network of approximately 2,000 offline distributors and retailers who stock and sell the company's products.
  • Online shoppers utilizing major Chinese e-commerce platforms and the company's direct digital channels.
AI Confidence: 73% Updated: Jun 14, 2026

ROE 8%Key Financial Metrics

Return on equity for China Feihe Limited stands at 7.7%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.7%, showing how much profit it generates from its asset base. CHFLF trades at a trailing price-to-earnings ratio of 12.66, below the Consumer Defensive sector average of ~29x. Its free cash flow yield is 2.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.00 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 8.4%, the inverse of the P/E and a quick read on earnings relative to price.

China Feihe Limited (CHFLF) Valuation Context

Valued at $3.08B, CHFLF is classified as a mid-cap stock. Relative to its peer group, CHFLF's quantitative score of 52/100 is roughly in line with the peer average of 57/100.

Company Profile

China Feihe Limited operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Beijing, CN. The company is led by CEO Youbin Leng. CHFLF has traded publicly since 2022.

F-Score 7/9Financial Health

China Feihe Limited's Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 4.70 places it in the safe zone, indicating low near-term bankruptcy risk.

FY2026 estForward Outlook

Wall Street analysts project China Feihe Limited revenue of about $18.59B for fiscal 2026, with EPS near $0.27. The estimate reflects 14 contributing analysts.

CHFLF Financials

Fundamental Snapshot

Revenue Growth (FY)
-15.0%
Net Income Growth (FY)
-45.7%
EPS Growth (FY)
-46.2%
Free Cash Flow Growth (FY)
-76.0%
P/E (TTM)
12.0
Return on Equity (TTM)
+7.7%
Current Ratio
3.0
EV/EBITDA (TTM)
4.5

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Extensive distribution network with 110,000 retail points of sale as of December 31, 2021, ensuring broad market reach.
  • Diversified product portfolio beyond infant milk formula, including adult milk powders, health care products, and nutritional supplements.
  • Strong gross margin of 65.0%, indicating efficient cost management and potential pricing power.
  • Long operating history since 1962, contributing to brand recognition and consumer trust.

Bear Case

  • High reliance on the Chinese market, making it susceptible to regional economic and regulatory shifts.
  • Potential for intense competition within the infant milk formula sector from both domestic and international brands.
  • Disclosure status on the OTC market is 'Unknown', potentially limiting investor access to timely and comprehensive financial information.
  • Specific brand names and their individual market positions are not detailed in the provided source data.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

CHFLF Latest News

CHFLF Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CHFLF.

Price Targets

Wall Street price target analysis for CHFLF.

CHFLF MoonshotScore

52/100

What does this score mean?

The MoonshotScore rates CHFLF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Youbin Leng

CEO

Youbin Leng serves as the Chief Executive Officer, overseeing the strategic direction and operational management of China Feihe Limited, a company with a significant workforce of 9,590 employees. While specific details regarding his extensive career history, educational background, and previous leadership roles prior to his current tenure at China Feihe are not explicitly provided in the available source data, his position at the helm of such a large organization suggests a substantial professional background in the consumer defensive or packaged foods sector. His leadership is critical for guiding the company's product development, market expansion, and distribution strategies across Mainland China and the United States.

Track Record: Specific achievements, strategic decisions, or company milestones directly attributable to Youbin Leng's leadership tenure are not detailed within the provided source information. Therefore, a comprehensive assessment of his track record, including key initiatives or significant financial performance under his guidance, cannot be formulated based on the available data. His role involves steering the company's operations and growth in a dynamic market environment.

CHFLF OTC Market Information

The 'OTC Other' tier for China Feihe Limited signifies that the company trades on the over-the-counter market but does not meet the requirements for higher tiers like OTCQX or OTCQB. Unlike stocks listed on major exchanges such as the NYSE or NASDAQ, which have stringent listing standards for financial health, corporate governance, and disclosure, 'OTC Other' companies face fewer regulatory hurdles. This tier often includes companies that are not required to or choose not to report to the SEC, or those that do not meet minimum price or financial standards for other OTC tiers. Investors should be aware of the inherent differences in transparency and liquidity compared to exchange-listed securities.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Trading on the OTC market, particularly in the 'OTC Other' tier, often implies lower liquidity compared to major exchanges. This can result in wider bid-ask spreads, making it more difficult for investors to buy or sell shares at desired prices. Lower trading volumes can also lead to increased price volatility and challenges in executing large orders without significantly impacting the stock price. Investors may experience delays or difficulties in converting their holdings into cash.
OTC Risk Factors:
  • Lack of transparent and consistent financial reporting due to 'Unknown' disclosure status, hindering informed investment decisions.
  • Lower trading volume and wider bid-ask spreads, leading to reduced liquidity and potential difficulty in executing trades.
  • Increased price volatility compared to exchange-listed stocks, making valuations and risk assessments more challenging.
  • Limited regulatory oversight from bodies like the SEC, potentially exposing investors to greater risks.
  • Difficulty in obtaining reliable and timely information for comprehensive due diligence.
Due Diligence Checklist:
  • Verify any available financial statements, even if unaudited, for key performance indicators and financial health.
  • Research management's background and track record through independent sources to assess leadership credibility.
  • Thoroughly understand the company's business model, revenue streams, and competitive landscape within its sector.
  • Assess the company's market capitalization and historical trading volume to gauge liquidity and market interest.
  • Investigate any news or press releases from the company or reputable third-party sources for material updates.
  • Examine the company's official website and any investor relations sections for voluntary disclosures.
  • Consider the potential impact of regulatory environment changes in China on its operations and market access.
Legitimacy Signals:
  • Long operating history since 1962, indicating an established and enduring business presence.
  • Significant employee base of 9,590, suggesting a substantial operational scale and infrastructure.
  • Established product lines including infant milk formula and health care products with market presence.
  • Utilizes major e-commerce platforms like Tmall and JD.com for sales, indicating modern market engagement.
  • Substantial market capitalization of $3.08B, reflecting a sizable enterprise value.

What Investors Ask About China Feihe Limited (CHFLF) — Consumer Defensive

What does China Feihe Limited do?

China Feihe Limited operates as an investment holding company primarily engaged in the production and sale of infant milk formula products within Mainland China and the United States. The company has diversified its offerings to include a comprehensive range of raw milk, adult milk powders, liquid milk products, and various health care products, alongside soybean powder and goat milk powder. Furthermore, it is involved in the retail of vitamins, minerals, herbs, and other nutritional supplements. Its extensive distribution strategy combines traditional distributors with a robust e-commerce presence on platforms such as Tmall, JD.com, and Suning.com, complemented by its own website and mobile application, including WeChat. As of December 31, 2021, the company boasted a significant offline distribution network comprising approximately 2,000 customers and 110,000 retail points of sale, underscoring its broad market reach.

How does China Feihe Limited manage supply chain and input cost risks?

While specific details on China Feihe Limited's supply chain risk management strategies are not explicitly provided, its extensive operating history since 1962 and its substantial gross margin of 65.0% suggest a degree of operational efficiency and potentially effective cost control mechanisms. As a producer of milk-based products, the company is inherently exposed to fluctuations in raw milk prices, which represent a significant input cost. Diversification into various product categories, including adult milk powders and health care products, may help mitigate reliance on a single commodity or product line. The company's broad distribution network, encompassing both offline and online channels, could also provide flexibility in managing inventory and responding to market demand shifts, thereby indirectly influencing supply chain resilience. However, without specific disclosures on hedging strategies or long-term supplier contracts, the precise methods for managing these risks remain largely unstated.

What are the main risks for CHFLF, particularly as an OTC-traded company?

China Feihe Limited faces several key risks, exacerbated by its trading status on the OTC market. Operationally, the company contends with intense competition within the infant milk formula sector in China, alongside potential shifts in consumer preferences and the ongoing challenge of fluctuating raw material costs, particularly for milk. Regulatory changes in China's stringent food safety standards or import policies could also significantly impact its production and distribution capabilities. As an OTC-traded company with an 'Unknown' disclosure status, CHFLF presents additional risks including limited transparency, making it difficult for investors to access consistent, audited financial reports. This can lead to lower liquidity, wider bid-ask spreads, and increased price volatility compared to stocks on major exchanges, alongside reduced regulatory oversight, requiring investors to undertake extensive due diligence.

What are China Feihe Limited's strongest brands and market positions?

While the provided source data does not explicitly name China Feihe Limited's strongest brands, the company's core business in infant milk formula products in Mainland China and the United States, coupled with its extensive distribution network, suggests a significant market presence within these segments. As of December 31, 2021, its operation through approximately 2,000 offline customers with 110,000 retail points of sale, alongside major e-commerce platforms like Tmall and JD.com, indicates a broad reach and established consumer access. This widespread availability and long operating history since 1962 are indicative of a strong, albeit unnamed, brand equity and a competitive position in the packaged foods industry, particularly within the infant and adult nutrition categories in its primary markets. The company's diversification into health care products and nutritional supplements further solidifies its market footprint.

What are the key factors to evaluate for CHFLF?

China Feihe Limited (CHFLF) holds an AI score of 52/100 (moderate). P/E: 12.7x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does CHFLF data refresh on this page?

CHFLF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven CHFLF's recent stock price performance?

China Feihe Limited (CHFLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Extensive distribution network with 110,000 retail points of sale as of December 31, 2021, ensuring broad market reach. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider CHFLF overvalued or undervalued right now?

China Feihe Limited (CHFLF) trades at 12.7x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information on CEO's specific career history, education, and track record is not available in the provided source data.
  • Specific brand names and their individual market positions are not detailed in the provided source data.
  • Detailed financial reports and analyst coverage information are not available in the provided source data for a comprehensive analyst consensus.
Data Sources

Popular Stocks